Back to Primary literature
Primary-literature peptidehigh evidence

PEPDIA-PLP-001112

GRVPR

Aliases: GRVPR

Normalized sequence

GRVPR

5 amino acids

Release PepDiana-V1-20260620

12

Activity records

1

Source papers

10

Positive

2

Negative / threshold

Versioned scientific descriptors

Physicochemical properties and standard representations

calculated sequence and structure

Reported properties

No separate physicochemical property was reported in the primary-literature identity record. PepDiana release values are shown as computed properties.

Computed properties

physchem-20260620

Molecular weight

583.6842 Da

Molecular formula

C24H45N11O6

Theoretical pI

12

Net charge at pH 7

1.7601

GRAVY

-1.36

Instability index

31.44

Aromaticity

0

Topological polar surface area

294.73 Ų

cLogP

-3.3424

Hydrogen-bond donors

11

Hydrogen-bond acceptors

8

Rotatable bonds

17

Method: PepDiana sequence/structure descriptor pipeline

Tool: Biopython+RDKit · Biopython 1.85; RDKit 2024.09.6

Calculated: 2026-06-20T11:01:38.358971+00:00

Assumptions: ph=7; termini=free N-terminus and free C-terminus for simple linear peptides; stereochemistry=standard L-amino acids; smiles_length_limit=200

Sequence representations

representations-20260620

ProForma 2.0

validated simple linear

GRVPR

HELM 2.0

validated simple linear

PEPTIDE1{G.R.V.P.R}$$$$V2.0

Canonical SMILES

validated

CC(C)C(NC(=O)C(CCCNC(=N)N)NC(=O)CN)C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)O

Isomeric SMILES

validated

CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

Paper-level observations

Experimental evidence grouped by activity

Antioxidant 6 records

PMC13117951

6 observations
AntioxidantCytotoxicNegative / threshold
Record detail

pretreatment with tuna peptides S1, S5, S6, and S7 significantly restored viability, with S6 and S7 exhibiting efficacy comparable to the positive drug (p < 0.001) (Figure 1B).

Measure
cell_viability
Value
significantly restored viability, efficacy comparable to positive drug
Target
Mus musculus
Assay
Not reported by source
Source publication
AntioxidantPositive observation
Record detail

pretreatment with S1, S5, S6, and S7 significantly reduced ROS levels in a concentration-dependent manner. (Figure 2A,B)

Measure
other
Value
significantly reduced ROS levels in a concentration-dependent manner
Target
Mus musculus
Assay
Not reported by source
Source publication
AntioxidantPositive observation
Record detail

In comparison to the model group, all tuna peptide treatment groups at a concentration of 200 μM demonstrated enhanced cellular antioxidant capacity... (Figure 3)

Measure
other
Value
enhanced cellular antioxidant capacity (increased CAT, SOD, GSH; reduced MDA)
Target
Mus musculus
Assay
Not reported by source
Source publication
AntioxidantPositive observation
Record detail

treatment with tuna peptides S1, S5, S6, and S7, resulted in a significant reduction in green fluorescence and a notable increase in red fluorescence (p < 0.001)... (Figure 6)

Measure
other
Value
significantly restored MMP
Target
Mus musculus
Assay
Not reported by source
Source publication
AntioxidantPositive observation
Record detail

pretreatment with 200 μM tuna peptides S1, S5, S6, and S7 significantly increased Nrf2 mRNA expression and decreased Keap1 mRNA expression in MLE-12 cells compared to the model group. (Figure 8)

Measure
other
Value
significantly increased Nrf2 mRNA, decreased Keap1 mRNA
Target
Mus musculus
Assay
Not reported by source
Source publication
AntioxidantPositive observation
Record detail

At a concentration of 200 μM, the nuclear Nrf2 levels in the S1 and S6 peptide-treated groups showed significant higher compared to the model group (p < 0.05). (Figure 9)

Measure
other
Value
significantly higher nuclear Nrf2
Target
Mus musculus
Assay
Not reported by source
Source publication
Immunomodulatory 2 records

PMC13117951

2 observations
ImmunomodulatoryAnti-inflammatoryPositive observation
Record detail

tuna peptide S6 demonstrated the strongest anti-inflammatory effect... At a concentration of 200 μM, the tuna peptide treatment groups (S1, S6, and S7) showed a significant reduction in these inflammatory markers compared to the model group. (Figure 4)

Measure
other
Value
strongest anti-inflammatory effect; significantly reduced IL-1β, IL-6, TNF-α
Target
Mus musculus
Assay
Not reported by source
Source publication
ImmunomodulatoryAnti-inflammatoryPositive observation
Record detail

treatment with 200 µM tuna peptides S1, S5, S6, and S7 significantly reduced p65 mRNA expression and increased IκBα mRNA expression (p < 0.001). (Figure 11A,B)

Measure
other
Value
significantly reduced p65 mRNA, increased IκBα mRNA
Target
Mus musculus
Assay
Not reported by source
Source publication
Anticancer 2 records

PMC13117951

2 observations
AnticancerPositive observation
Record detail

Among these, the 200 µM concentration of peptide S6 exhibited a stronger inhibitory effect on CSE-induced apoptosis in MLE-12 cells. (Figure 5)

Measure
other
Value
stronger inhibitory effect on apoptosis
Target
Mus musculus
Assay
Not reported by source
Source publication
AnticancerPositive observation
Record detail

pretreatment with 200 μM tuna peptides S1, S5, S6, and S7 significantly increased the Bcl-2/Bax mRNA expression ratio compared to the model group, with highly significant differences (p < 0.001). (Figure 11C)

Measure
other
Value
significantly increased Bcl-2/Bax mRNA ratio
Target
Mus musculus
Assay
Not reported by source
Source publication
Toxicity 1 records

PMC13117951

1 observations
ToxicityCytotoxicNegative / threshold
Record detail

To assess the safety of tuna peptides, cells were treated with 200 µM of peptide S1–8, which maintained viability above 90%... (Figure 1B).

Measure
cell_viability
Value
above 90%
Target
Mus musculus
Assay
Not reported by source
Source publication
Other 1 records

PMC13117951

1 observations
OtherPositive observation
Record detail

tuna peptides S1, S5, S6, and S7 significantly promote the migration of MLE-12 cells and accelerate wound closure in a concentration-dependent manner. (Figure 7)

Measure
other
Value
significantly promoted cell migration in a concentration-dependent manner
Target
Mus musculus
Assay
Not reported by source
Source publication

Citation and release provenance

Cite this identity as PepDiana record PEPDIA-PLP-001112, release PepDiana-V1-20260620. Experimental observations retain their paper, mention, and activity-record identifiers.

Record updated: 2026-06-22T07:14:26.229247+00:00